Sign In
Last checked at 
24 Jul 2018 15:57
24 July 2018
Kainos Group plc
("Kainos" or the "Company)
Director / PDMR shareholdings
The Company has been notified that on 24 July 2018, that Paul Gannon, Director, has exercised options over 68,345 ordinary shares of £0.005 at an exercise price of £0.005 per ordinary share.
Following this notification, Paul Gannon and his Connected Person have a reportable shareholding of 8,499,585 ordinary shares in the issued share capital of the Company, constituting 7.14% of the issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Paul Gannon | ||||
2. | Reason for the notification | |||||
a. | Position/status | Business Development Director | ||||
b. | Initial notification /Amendment | Initial | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Kainos Group plc | ||||
b. | LEI | 213800H2PQMIF3OVZY47 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument/ type of instrument Identification code | Ordinary Shares of £0.005 each
KNOS | ||||
b. | Nature of the transaction | Exercise of Options | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price |
N/A | ||||
e. | Date of the transaction | 2018-07-24 | ||||
f. | Place of the transaction | LSE - Regulated Market - XLON | ||||
Kainos Group Limited Legal Entity Identifier: 213800H2PQMIF3OVZY47
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc 44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.
The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.
The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.
Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com
Follow the stocks
